Cholesterol as a mediator of hepatic injury in non-alcoholic steatohepatitis

作者
Van Rooyen, Derrick Michael
出处
期刊:Australian National University - ANU Open Research [Australian National University]
标识
DOI:10.25911/5d5e70d130523
摘要

Non-alcoholic fatty liver disease (NAFLD) is highly prevalent. 20-30% of patients with NAFLD progress to non-alcoholic steatohepatitis (NASH), characterised by steatosis, ballooning degeneration of hepatocytes, inflammation and fibrosis, but the cause(s) of this transition remains unclear. Foz/foz (Alms1 mutant) mice develop hyperphagia and obesity-related NAFLD. High fat (HF)-feeding induces NASH transition by 12 weeks, and fibrosis by 24 weeks. The aims of this research were to investigate the cause and effect of hepatic cholesterol dysregulation in foz/foz mice, its pathogenic significance in NASH, and the potential of dietary and pharmacological approaches to treat NASH. After 24 weeks HF-feeding, hepatic free cholesterol (FC) and cholesteryl ester (CE) content were markedly increased in foz/foz mice. Hepatic cholesterol accumulation was associated with increased expression of low-density lipoprotein receptor (LDLR), but not cholesterol synthesis. Bile acid (BA) biosynthesis genes were suppressed, as was expression of cholesterol and BA export proteins. Transcriptional regulators of cholesterol metabolism were differentially expressed in foz/foz mice with NASH: SREBP-2, a nuclear regulator of LDLR increased significantly, while LXR-a and HNF-4a decreased. Importantly, expression of liver receptor homolog-1 (LRH-1), while significantly elevated in HF-fed WT mice, was unaltered in HF-fed foz/foz mice. To test whether hyperinsulinaemia was responsible for some or all of these changes, experiments were conducted in primary murine hepatocyte cultures. Insulin activated both SREBP-2 and LDLR, while simultaneously decreasing BA export proteins and LRH-1 expression. Removing dietary cholesterol in HF-fed foz/foz mice ameliorated liver injury, whereas increasing dietary cholesterol accentuated injury. Steatohepatitis severity correlated with hepatic FC and CE, but not hepatic triglyceride or free fatty acids. Hepatic cholesterol loading activated nuclear factor (NF)-kB and c-Jun N-terminal kinase (JNK), and increased serum monocyte chemotactic protein (MCP)-1. Finally, quantitative analysis of sirius red staining demonstrated a positive relationship between hepatic cholesterol content and fibrosis severity. To establish whether pharmacological modulation of cholesterol turnover could modulate NASH outcome, HF-fed foz/foz and WT mice were administered atorvastatin and/or ezetimibe after NASH onset. Both agents significantly lowered hepatic CE and FC, serum ALT, total cholesterol and HDL and normalised liver size in foz/foz mice. Hepatocellular apoptosis and expression of inflammatory mediators was suppressed as was hepatic macrophage infiltration. While histological steatosis and ballooning scores were unaltered, lobular inflammation and liver fibrosis were significantly reduced in drug-treated foz/foz mice. In foz/foz mice, NASH is associated with profoundly disordered hepatic cholesterol turnover. Insulin-induced activation of SREBP-2 and suppression of LRH-1 likely result in increased LDLR expression and suppression of genes involved in cholesterol biotransformation and export. Consequently, cholesterol accumulates within the livers of foz/foz mice. The evidence from both dietary and pharmacological intervention experiments is that hepatic cholesterol mediates hepatocellular apoptosis, inflammatory cell recruitment and liver fibrosis in this model. Conversely, inhibition of cholesterol uptake/redistribution and biosynthesis, and dietary cholesterol restriction, reduces liver injury, inflammation, and fibrosis in foz/foz mice with NASH. These findings strongly support the hypothesis that hepatic cholesterol, secondary to insulin resistance, acts as a lipotoxic mediator of pro-fibrotic liver injury and inflammation in experimental NASH. -- provided by Candidate.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
刚刚
谢美阳阳完成签到,获得积分10
刚刚
先锋老刘001完成签到,获得积分10
刚刚
李李完成签到,获得积分10
1秒前
1秒前
顾矜的应助被wfc采纳,获得10
1秒前
喵呜啦啦啦啦完成签到,获得积分10
2秒前
2秒前
2秒前
Monicadd完成签到 ,获得积分10
4秒前
CITY111119发布了新的文献求助50
4秒前
min发布了新的文献求助10
4秒前
AJKLDJAK发布了新的文献求助10
5秒前
5秒前
Imagine发布了新的文献求助10
5秒前
何雨航发布了新的文献求助10
5秒前
panzerVI完成签到,获得积分10
5秒前
果子完成签到,获得积分20
5秒前
6秒前
6秒前
7秒前
7秒前
8秒前
茉云完成签到,获得积分10
8秒前
9秒前
晚霞跌落星河的应助被MADAO采纳,获得30
9秒前
小珂完成签到,获得积分10
10秒前
FossilGitter8发布了新的文献求助10
10秒前
英姑的应助被酷酷的冬灵采纳,获得50
10秒前
受伤白安发布了新的文献求助10
11秒前
cosscant发布了新的文献求助10
11秒前
春天完成签到 ,获得积分10
12秒前
12秒前
12秒前
13秒前
cxxxxx完成签到,获得积分10
13秒前
13秒前
13秒前
魏伯安发布了新的文献求助10
14秒前
七号楼少女完成签到,获得积分10
14秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
八旗制度の研究 600
Boundaries and Bodhisattvas 500
高分子基功能界面水蒸发材料与应用研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8182014
求助须知:如何正确求助?哪些是违规求助? 9571728
关于积分的说明 21819478
捐赠科研通 7778441
什么是DOI,文献DOI怎么找? 3433580
关于科研通互助平台的介绍 2557781
邀请新用户注册赠送积分活动 2479640